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● Context.—Recently, prostatic atrophy associated with
chronic inflammation has been linked to carcinoma either
directly or indirectly by first developing into high-grade
prostatic intraepithelial neoplasia.
Objective.—The purpose of our study was to test this
hypothesis in autopsies.
Design.—A step section method was used to cut the pos-
terior lobe in coronal planes at intervals of 0.3 to 0.5 cm
in 100 consecutive autopsies of men older than 40 years.
Prostatic atrophy was classified as simple, hyperplastic (or
postatrophic hyperplasia), and sclerotic and was analyzed
for the presence of chronic inflammation. Prostatic atro-
phy without (group A) and with inflammation (group B)
was correlated with the following variables: age, race, his-
tologic (incidental) carcinoma, high-grade prostatic intra-
epithelial neoplasia, and extent of both these lesions.
Results.—Of the 100 prostates examined, 12%, 22%
and 66%, respectively, had no atrophy, atrophy without
inflammation (group A), and atrophy with inflammation
(group B). There was no statistically significant difference
between groups A and B for age (P 5 .55), race (P 5 .89),
presence of histologic (incidental) carcinoma (P 5 .89),
extensive carcinoma (P 5 .43), presence of high-grade
prostatic intraepithelial neoplasia (P 5 .65), extensive high-
grade intraepithelial neoplasia (P 5 .30), or subtypes of
prostatic atrophy. Neither a topographical relation nor a
morphologic transition was seen between prostatic atrophy
and histologic carcinoma or high-grade intraepithelial neo-
plasia. Sclerotic atrophy either alone or combined with
other subtypes was more frequent in the group with in-
flammation. A striking morphologic finding was a topo-
graphical relation of focal inflammation with sclerotic at-
rophy in areas with erosion of the epithelium.
Conclusions.—Inflammatory prostatic atrophy does not
appear to be associated with histologic (incidental) carci-
noma or high-grade intraepithelial neoplasia. One possible
cause of inflammatory infiltrate associated with prostatic
atrophy may be the extravasated prostatic secretions,
which were noted in areas of eroded epithelium, a com-
mon finding in the sclerotic type of prostatic atrophy.
(Arch Pathol Lab Med. 2003;127:840–844)
Chronic inflammation of long-standing duration hasbeen linked to the development of carcinoma in sev-
eral organ systems.1–3 In the prostate, chronic inflamma-
tion is associated with both postatrophic hyperplasia and
focal simple atrophy.4 De Marzo et al5 proposed combin-
ing these lesions into a category called proliferative inflam-
matory atrophy (PIA). The authors suggested that PIA may
be a precursor to prostatic adenocarcinoma. They also
suggested that there are morphologic transitions within
the same acinar/duct unit between high-grade prostatic
intraepithelial neoplasia (HGPIN) and PIA, which occur
frequently.4 This finding supports a model in which the
proliferative epithelium in PIA may progress to HGPIN.
The purpose of our study was to test this hypothesis in
autopsies.
Accepted for publication February 19, 2003.
From the Departments of Anatomic Pathology (Dr Billis) and Medical
Genetics and Statistics (Dr Magna), School of Medicine, State Univer-
sity of Campinas (UNICAMP), Campinas, Brazil.
Presented at the 90th Annual Meeting of the United States and Ca-
nadian Academy of Pathology, Atlanta, Ga, March 3–9, 2001.
Reprints: Athanase Billis, MD, Departamento de Anatomia Patoló-
gica, Faculdade de Ciências Médicas—UNICAMP, Caixa Postal 6111,
CEP 13083-970 Campinas, SP, Brazil (e-mail: athanase@fcm.
unicamp.br).
MATERIALS AND METHODS
The material for this retrospective study was obtained from
100 consecutive autopsies of men older than 40 years who died
of diseases other than carcinoma of the prostate. Autopsies were
conducted at the University Hospital, a general hospital and the
main teaching hospital of the School of Medicine, State University
of Campinas (UNICAMP), Campinas, Brazil. Race of the patients
was considered to be either white or African Brazilian. In Brazil,
the African Brazilian population comprises blacks and mulattos
(persons of mixed white and black ancestry).
The prostates were dissected free from the surrounding tissue
and fixed uncut in 10% formalin for 5 days or longer. The glands
were cut in 2 parts through a sagittal section passing through
the middle of the organ. The ejaculatory ducts were easily visu-
alized on each section plane because of the presence of yellow-
brown pigment. The prostate was sectioned through the plane
indicated by the presence of the ejaculatory duct. The posterior
lobe was considered to be that portion of the gland lying poste-
rior to a plane passing the ejaculatory ducts, according to Moore,6
Kahler,7 and Strahan,8 and corresponds to the largest part of the
peripheral zone, according to McNeal’s classification.9
The glands were step-sectioned at intervals of 3 to 5 mm. Only
the posterior lobe was examined microscopically. Blocks were
embedded in paraffin, cut at 6 mm, and 1 section from each block
was stained with hematoxylin-eosin.
The microscopic study looked for the following features:
1. Presence of prostatic atrophy. Prostatic atrophy was histo-
logically subtyped into simple atrophy, hyperplastic atrophy (or
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Figure 1. Simple atrophy with inflammation (hematoxylin-eosin, original magnification 3210).
Figure 2. Hyperplastic atrophy (or postatrophic hyperplasia) with inflammation (hematoxylin-eosin, original magnification 3100).
Figure 3. Sclerotic atrophy with inflammation. Advanced stage of sclerotic atrophy with complete destruction of the epithelium. Inflammation is
seen in and around the lumen of the acinus (hematoxylin-eosin, original magnification 3100).
Figure 4. Morphologic transition between high-grade prostatic intraepithelial neoplasia (HGPIN) and microinvasive carcinoma. No such contin-
uum was seen between any type of prostatic atrophy (with or without inflammation) and HGPIN or histologic carcinoma (hematoxylin-eosin,
3330).
postatrophic hyperplasia), and sclerotic atrophy.10 Simple atrophy
(Figure 1) usually involves an entire lobule, although isolated ac-
ini may be affected. The acini are small and show a decrease in
the height of the epithelial cells, and the surrounding stroma may
or may not show fibrosis. Hyperplastic atrophy (Figure 2) shows
small acini packed closely together and lined by atrophic epithe-
lium. Fibrosis may or may not be present in the stroma. When
present, the proliferation is irregular and can result in distortion
of the acinar lumen. Sclerotic atrophy (Figure 3) shows simulta-
neous atrophy of the epithelium and proliferation of the fibro-
blasts about the acini, which progressively dilate. Elastosis of the
stroma was a useful microscopic feature for the identification of
prostatic atrophy of any subtype.11
2. Presence of atrophy with inflammation (or inflammatory at-
rophy) (Figures 1 through 3). This lesion was considered when
chronic inflammation (as judged mostly by the presence of lym-
phocytes) was seen in areas of prostatic atrophy of any kind (sim-
ple, hyperplastic, or sclerotic).
3. Presence of histologic (incidental) carcinoma (HC). Histo-
logic carcinoma was diagnosed according to the criteria of Mos-
tofi and Price.12 The diagnosis was based on invasion or architec-
tural disturbance.
4. Presence of HGPIN. Four common patterns of HGPIN were
identified, all with nucleomegaly and prominent nucleoli. The
patterns were described as tufting, micropapillary, cribriform,
and flat, according to Bostwick et al.13
5. Evaluation of extent of lesions. Extent was evaluated accord-
ing to the percentage of sections that showed the lesion of inter-
est. When more than 50% of the sections per prostate showed
the lesion, it was considered extensive. A total of 1384 sections
were examined (average of 14 sections per prostate).
The data were statistically analyzed by the x2 test and Fisher
exact test for differences between proportions. P # .05 was con-
sidered statistically significant. The comparison of age between
groups was done using the Mann-Whitney nonparametric statis-
tical test.
RESULTS
Of the 100 prostates examined, 12%, 22%, and 66%, re-
spectively, had no atrophy, atrophy without inflammation
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Table 1. Comparison Between 22 Prostates Without Inflammation (Group A) and 66 Prostates With Inflammation (or
Inflammatory Atrophy) (Group B) for Race, Histologic (Incidental) Carcinoma (HC), Extent of HC, High-Grade Prostatic
Intraepithelial Neoplasia (HGPIN), and Extent of HGPIN

























Table 2. Frequency of Subtypes of Prostatic Atrophy in Groups A (Without Inflammation) and B (With Inflammation)













Combined subtypes 16/22 (72.72) 36/66 (54.54) .13
















* S indicates simple atrophy; H, hyperplastic atrophy; and SC, sclerotic atrophy
(group A), and atrophy with inflammation (or inflamma-
tory atrophy) (group B).
The median age for patients was 58 years in group A
and 64 years in group B. There was a trend for higher age
in patients with atrophy with inflammation (P 5 .06).
Sixteen (72.72%) and 6 (27.27%) of the 22 patients in
group A, and 49 (74.24%) and 17 (25.75%) of the 66 pa-
tients in group B were white and African Brazilian, re-
spectively.
Histologic carcinoma was found in 24 (24%) of the 100
prostates examined, including 3 (25%) of the 12 cases
without atrophy, 5 (22.72%) of the 22 cases in group A,
and 16 (24.24%) of the 66 cases in group B. In 1 (20%) of
the 5 patients with HC in group A and 1 (6.25%) of the
16 patients with HC in group B, involvement was exten-
sive.
High-grade prostatic intraepithelial neoplasia was
found in 78 (78%) of the 100 prostates examined, including
9 (75%) of the 12 cases in the group without atrophy, 16
(72.72%) of the 22 cases in group A, and 53 (80.30%) of
the 66 cases in group B. In 6 (37.5%) of the 16 patients
with HGPIN in group A and 11 (20.75%) of the 53 patients
with HGPIN in group B, involvement was extensive.
There was no statistically significant difference between
groups A and B with respect to race (P 5 .89), HC (P 5
.89), extensive HC (P 5 .43), HGPIN (P 5 .65), and exten-
sive HGPIN (P 5 .30) (Table 1).
There was no topographical relation of inflammatory at-
rophy with either HGPIN or HC. Morphologic transition
between atrophic acini with or without inflammation and
HC or HGPIN was not seen in any case. Of the total of 78
patients with HGPIN, we found a continuum between
HGPIN and invasive adenocarcinoma in only 2 (2.56%)
(Figure 4).
According to the subtypes of prostatic atrophy, simple
atrophy was seen in groups A and B in 4 (18.18%) of 22
patients and 10 (15.15%) of 66 patients, respectively; scle-
rotic atrophy was noted in 2 (9.09%) and 15 (22.72%) pa-
tients, respectively; hyperplastic atrophy was observed in
0 and 5 patients (7.57%), respectively; and combined sub-
types were seen in 16 (72.72%) and 36 (54.54%) patients,
respectively.
There was no statistically significant difference between
groups A and B according to the subtypes of prostatic
atrophy (Table 2); however, sclerotic atrophy was seen
more frequently in group B (prostatic atrophy with inflam-
mation) and this difference was statistically significant (P
5 .03) when combined with the hyperplastic subtype. A
striking topographic relationship of focal inflammation
and sclerotic atrophy was seen in areas with erosion of the
epithelium (Figure 3).
COMMENT
The term proliferative inflammatory atrophy was proposed
by De Marzo et al5 to designate discrete foci of prolifera-
tive glandular epithelium with the morphologic appear-
ance of simple atrophy or postatrophic hyperplasia occur-
ring in association with inflammation. According to these
authors, the morphology of PIA is consistent with Mc-
Neal’s description of postinflammatory atrophy,14 with
that of chronic prostatitis described by Bennett et al,15 and
with the lesion referred to previously as ‘‘lymphocytic
prostatitis’’ by Blumenfeld et al.16
De Marzo et al5 and Putzi and De Marzo4 suggested
that PIA may indeed give rise to carcinoma directly, as
hypothesized previously, or that PIA may lead to carci-
noma indirectly via development into HGPIN. This hy-
pothesis is based on 3 separate findings providing sup-
portive evidence: (1) morphologic merging between PIA
and HGPIN in 34% of the PIA lesions; (2) the phenotype
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of many of the cells in PIA is most consistent with that of
an immature secretory-type cell, similar to that for the
cells of HGPIN; and (3) PIA, HGPIN, and carcinoma all
occur with high prevalence in the peripheral zone and low
prevalence in the central zone of the human prostate.
Three articles are at odds with the findings of De Marzo
et al5 and Putzi and De Marzo.4 In the only study done in
Brazil, in which 100 prostates were examined in autopsies,
no relation, including topographical, was found between
prostatic atrophy of any subtype and HC or HGPIN.10 In
this latter study, no reference was made to atrophy with
inflammation. Anton et al,17 studying radical prostatecto-
mies, concluded that postatrophic hyperplasia is a rela-
tively common lesion that is present in about one third of
prostates, with or without prostate carcinoma. The authors
found no association between the presence of postatrophic
hyperplasia and the likelihood of cancer and no topo-
graphic association between postatrophic hyperplasia and
prostate carcinoma foci. This finding held true for both
clinical cancer in a radical prostatectomy specimen and
incidental cancer in a cystoprostatectomy specimen.17 In a
recent report, Bakshi et al18 studied 79 consecutive pros-
tate biopsies. Fifty-four percent of initial biopsies were be-
nign, 42% of the cases showed cancer, and 4% demonstrat-
ed HGPIN or atypia. Postatrophic hyperplasia was seen
in 17% of benign initial biopsies with available follow-up.
Of these, 75% had associated inflammation. There was no
significant difference in the subsequent diagnosis of pros-
tate cancer for groups with postatrophic hyperplasia, par-
tial atrophy, atrophy, or no specific abnormality. The au-
thors concluded that the subcategories of atrophy did not
appear to be associated with a significant increase in the
risk of diagnosis of prostate cancer subsequently.
The purpose of the present study was to find any re-
lation of inflammatory atrophy to either HC or HGPIN.
Of a total of 100 prostates examined, 66 showed chronic
inflammation of any the subtypes of atrophy (simple, hy-
perplastic, or sclerotic). When compared with 22 prostates
with no inflammation of any subtype, no significant dif-
ference was found for age, race, HC, or HGPIN.
No significant difference was found between atrophy
and HC (P 5 .61) or HGPIN (P 5 .96), even considering
the hyperplastic subtype of atrophy (present as the only
lesion or combined with other subtypes). It is noteworthy
that only a few cases demonstrated hyperplastic atrophy
as the only subtype (5/88, 5.68%). In most of the cases,
this lesion was seen combined with the other subtypes of
atrophy (40/88, 45.45%). This finding supports the hy-
pothesis that prostatic atrophy is a morphologic continu-
um and that hyperplastic subtype (or postatrophic hyper-
plasia) seems to be at the extreme end of this morphologic
continuum of acinar atrophy, which most closely mimics
adenocarcinoma.10
There was no topographical relation of PIA with either
HC or HGPIN. Even considering extent of involvement,
prostatic atrophy without inflammation (group A) and
PIA (group B) were equally seen associated with extensive
and not extensive HC or HGPIN. No case demonstrated
morphologic transition between prostatic atrophy with or
without inflammation and HC or HGPIN. The only con-
tinuum seen in this series was a morphologic transition
between HGPIN and invasive adenocarcinoma in 2
(2.56%) of 78 patients with HGPIN (Figure 4).
So far, HGPIN is the only and earliest morphologically
recognizable precursor lesion of prostate cancer19; how-
ever, the demonstration of a continuum between HGPIN
and microinvasion is rare. Such microinvasion is seen in
about 2% of high-power microscopic fields of HGPIN.20
Considering the subtypes of prostatic atrophy, a higher
frequency of sclerotic atrophy either alone or combined
with other subtypes was seen in group B, and the differ-
ence was statistically significant (P 5 .03) when combined
with the hyperplastic subtype. A striking finding was a
topographical relation of focal inflammation to sclerotic
atrophy in areas with erosion of the epithelium (Figure 3).
This finding suggests that the inflammatory infiltrate may
be secondary to prostatic secretion extravasated in areas
of eroded epithelium frequently seen in this subtype of
atrophy. Sclerotic atrophy is a peculiar subtype of prostatic
atrophy.6,10,11 It shows simultaneous atrophy of the epithe-
lium and proliferation of the fibroblasts about the acinus.
Continued proliferation results in hyalinization of the col-
lagen. With higher degrees of hyalinization the acini dilate,
sometimes prominently, and the epithelium becomes ex-
tremely flattened; eventually it disappears completely
(Figure 3). This subtype of prostatic atrophy was de-
scribed in detail by Moore in 1936.6
In conclusion, atrophy with chronic inflammation (or in-
flammatory atrophy) was seen in 66 (66%) of 100 prostates
examined at autopsy. In this study, we found no statisti-
cally significant difference between prostatic atrophy
without inflammation (group A) and prostatic atrophy
with inflammation (group B) in relation to age, race, or
presence of HC and HGPIN. Likewise, no difference was
seen when the extent of involvement of HC and HGPIN
was taken into account. Considering the subtypes of pros-
tatic atrophy, no significant difference was seen between
group A and group B, but sclerotic atrophy either alone
or combined with other subtypes was more frequent in
the group with inflammation. A striking morphologic
finding was a topographical relation of focal inflammation
with sclerotic atrophy in areas with erosion of the epithe-
lium. This finding suggests that the inflammatory infil-
trate may be secondary to prostatic secretion extravasated
in areas of eroded epithelium, which frequently occurs in
this subtype of atrophy.
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